Cost–effectiveness of statins revisited: lessons learned about the value of innovation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Link
http://link.springer.com/content/pdf/10.1007/s10198-011-0315-1.pdf
Reference38 articles.
1. Weinstein, M.C., Coxson, P.G., Williams, L.W., Pass, T.M., Stason, W.B., Goldman, L.: Forecasting coronary heart disease incidence, mortality, and cost: the Coronary Heart Disease Policy Model. Am. J. Public Health 77(11), 1417–1426 (1987)
2. Goldman, L., Weinstein, M.C., Goldman, P.A., Williams, L.W.: Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA 265(9), 1145–1151 (1991)
3. Tsevat, J., Weinstein, M.C., Williams, L.W., Tosteson, A.N., Goldman, L.: Expected gains in life expectancy from various coronary heart disease risk factor modifications. Circulation 83(4), 1194–1201 (1991)
4. Martens, L.L., Rutten, F.F., Erkelens, D.W., Ascoop, C.A.: Cost effectiveness of cholesterol-lowering therapy in The Netherlands Simvastatin versus cholestyramine. Am. J. Med. 87(4A), 54S–58S (1989)
5. Hjalte, K., Lindgren, B., Persson, U.: Cost-effectiveness of simvastatin versus cholestyramine: results for Sweden. Pharmacoeconomics 1(3), 213–216 (1992)
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A theory on ICER pricing and optimal levels of cost-effectiveness thresholds: a bargaining approach;Frontiers in Health Services;2023-08-24
2. The Allocation of the Economic Value of Second-Generation Antipsychotics Over the Product Life Cycle: The Case of Risperidone in Sweden and the United Kingdom;Value in Health;2023-03
3. Value appropriation in hepatitis C;The European Journal of Health Economics;2021-12-02
4. Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems;Health Economics;2021-08-02
5. Need for hyperlipidemia management policy reform in China: learning from the global experience;Current Medical Research and Opinion;2017-08-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3